What's Happening?
Procter & Gamble (P&G) has announced its acquisition of Thorne, a supplements brand, for $3.8 billion. The acquisition is part of P&G's strategy to expand its health and wellness division, which already
includes brands like Metamucil and Align Probiotic. Thorne, founded in 1984, has seen significant growth, with its annual revenue surpassing $500 million in 2025. The acquisition is expected to enhance P&G's portfolio in the health sector, leveraging Thorne's established market presence and operational efficiency.
Why It's Important?
This acquisition represents a significant expansion of P&G's health and wellness offerings, positioning the company to capitalize on the growing demand for supplements and health products. By integrating Thorne into its portfolio, P&G can leverage its distribution network and marketing expertise to drive further growth. The move also reflects a broader trend of consumer goods companies diversifying into health-related sectors, responding to increasing consumer focus on health and wellness. The acquisition could potentially lead to increased market share and revenue for P&G.
